Does Propecia (finasteride) cause side effects?
Propecia (finasteride) is used to treat male pattern baldness or androgenetic alopecia in males only. Propecia works by lowering levels of a hormone that shrinks hair follicles, called dihydrotestosterone (DHT).
It slows hair loss in about 88% of men and helps hair regrow in about 66%. Another finasteride oral dosage form, Proscar or 5 mg finasteride tablets are FDA approved only for the treatment of benign prostatic hyperplasia (BPH) and should not be used for androgenetic alopecia. Do not confuse these finasteride tablets.
Common side effects of Propecia include
Serious side effects of Propecia include
Drug interactions of Propecia include carbamazepine, rifampin, and St. John's wort, which may reduce blood levels of Propecia by increasing its breakdown in the liver. Itraconazole, erythromycin and similar drugs increase blood levels of Propecia.
Propecia should not be used or handled by pregnant mothers due to the potential hazard to the male fetus. Propecia prevents the conversion of testosterone to DHT, a hormone which is necessary for the development of male genitalia.
What are the important side effects of Propecia (finasteride)?
The most common side effects associated with finasteride are:
Propecia (1 mg finasteride) was approved by the FDA for the treatment of male pattern baldness in December 1997. Another finasteride oral dosage form, Proscar or 5 mg finasteride tablets are FDA approved only for the treatment of benign prostatic hyperplasia (BPH) and should not be used for androgenetic alopecia. Do not confuse these finasteride tablets.
Propecia (finasteride) side effects list for healthcare professionals
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Clinical Studies For Propecia (Finasteride 1 mg) In The Treatment Of Male Pattern Hair Loss
In three controlled clinical trials for Propecia of 12-month duration, 1.4% of patients taking Propecia (n=945) were discontinued due to adverse experiences that were considered to be possibly, probably or definitely drug-related (1.6% for placebo; n=934).
Clinical adverse experiences that were reported as possibly, probably or definitely drug-related in ≥1% of patients treated with Propecia or placebo are presented in Table 1.
TABLE 1: Drug-Related Adverse Experiences for Propecia (finasteride 1 mg) in
Year 1 (%)
MALE PATTERN HAIR LOSS
(Decreased Volume of
|Discontinuation due to drug-related sexual adverse experiences||1.2||0.9|
- Integrated analysis of clinical adverse experiences showed that during treatment with Propecia, 36 (3.8%) of 945 men had reported one or more of these adverse experiences as compared to 20 (2.1%) of 934 men treated with placebo (p=0.04).
- Resolution occurred in men who discontinued therapy with Propecia due to these side effects and in most of those who continued therapy.
- The incidence of each of the above adverse experiences decreased to ≤0.3% by the fifth year of treatment with Propecia.
- In a study of finasteride 1 mg daily in healthy men, a median decrease in ejaculate volume of 0.3 mL (- 11%) compared with 0.2 mL (-8%) for placebo was observed after 48 weeks of treatment.
- Two other studies showed that finasteride at 5 times the dosage of Propecia (5 mg daily) produced significant median decreases of approximately 0.5 mL (-25%) compared to placebo in ejaculate volume, but this was reversible after discontinuation of treatment.
- In the clinical studies with Propecia, the incidences for breast tenderness and enlargement, hypersensitivity reactions, and testicular pain in finasteride-treated patients were not different from those in patients treated with placebo.
Controlled Clinical Trials And Long-Term Open Extension Studies For Proscar® (Finasteride 5 mg) And AVODART (Dutasteride) In The Treatment Of Benign Prostatic Hyperplasia
In the Proscar Long-Term Efficacy and Safety Study (PLESS), a 4-year controlled clinical study, 3040 patients between the ages of 45 and 78 with symptomatic BPH and an enlarged prostate were evaluated for safety over a period of 4 years (1524 on Proscar 5 mg/day and 1516 on placebo). 3.7% (57 patients) treated with Proscar 5 mg and 2.1% (32 patients) treated with placebo discontinued therapy as a result of adverse reactions related to sexual function, which are the most frequently reported adverse reactions.
Table 2 presents the only clinical adverse reactions considered possibly, probably or definitely drug related by the investigator, for which the incidence on Proscar was ≥1% and greater than placebo over the 4 years of the study. In years 2-4 of the study, there was no significant difference between treatment groups in the incidences of impotence, decreased libido and ejaculation disorder.
TABLE 2: Drug-Related Adverse Experiences for Proscar
(finasteride 5 mg)
BENIGN PROSTATIC HYPERPLASIA
|Years 2, 3 and 4*
|Decreased Volume of Ejaculate||3.7||0.8||1.5||0.5|
|*Combined Years 2-4
N = 1524 and 1516, finasteride vs placebo, respectively
- The adverse experience profiles in the 1-year, placebo-controlled, Phase III BPH studies and the 5-year open extensions with Proscar 5 mg and PLESS were similar.
- There is no evidence of increased sexual adverse experiences with increased duration of treatment with Proscar 5 mg. New reports of drug-related sexual adverse experiences decreased with duration of therapy.
- During the 4- to 6-year placebo- and comparator-controlled Medical Therapy of Prostatic Symptoms (MTOPS) study that enrolled 3047 men, there were 4 cases of breast cancer in men treated with Proscar but no cases in men not treated with Proscar. During the 4-year placebo-controlled PLESS study that enrolled 3040 men, there were 2 cases of breast cancer in placebo-treated men, but no cases were reported in men treated with Proscar.
- During the 7-year placebo-controlled Prostate Cancer Prevention Trial (PCPT) that enrolled 18,882 men, there was 1 case of breast cancer in men treated with Proscar, and 1 case of breast cancer in men treated with placebo. The relationship between long-term use of finasteride and male breast neoplasia is currently unknown.
- The PCPT trial was a 7-year randomized, double-blind, placebo-controlled trial that enrolled 18,882 healthy men ≥55 years of age with a normal digital rectal examination and a PSA ≤3.0 ng/mL.
- Men received either Proscar (finasteride 5 mg) or placebo daily.
- Patients were evaluated annually with PSA and digital rectal exams. Biopsies were performed for elevated PSA, an abnormal digital rectal exam, or the end of study.
- The incidence of Gleason score 8-10 prostate cancer was higher in men treated with finasteride (1.8%) than in those treated with placebo (1.1%).
- In a 4-year placebo-controlled clinical trial with another 5α-reductase inhibitor [AVODART (dutasteride)], similar results for Gleason score 8-10 prostate cancer were observed (1% dutasteride vs 0.5% placebo). The clinical significance of these findings with respect to use of Propecia by men is unknown.
- No clinical benefit has been demonstrated in patients with prostate cancer treated with Proscar. Proscar is not approved to reduce the risk of developing prostate cancer.
The following adverse reactions have been identified during post approval use of Propecia. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:
sexual dysfunction that continued after discontinuation of treatment, including erectile dysfunction, libido disorders, ejaculation disorders, and orgasm disorders; male infertility and/or poor seminal quality (normalization or improvement of seminal quality has been reported after discontinuation of finasteride); testicular pain.
breast tenderness and enlargement;
What drugs interact with Propecia (finasteride)?
Cytochrome P450-Linked Drug Metabolizing Enzyme System
- No drug interactions of clinical importance have been identified.
- Finasteride does not appear to affect the cytochrome P450-linked drug-metabolizing enzyme system.
- Compounds that have been tested in man include
Other Concomitant Therapy
Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with
- acetylsalicylic acid,
- angiotensin-converting enzyme (ACE) inhibitors,
- beta blockers,
- calcium-channel blockers,
- cardiac nitrates,
- H2 antagonists,
- HMG-CoA reductase inhibitors,
- prostaglandin synthetase inhibitors (also referred to as NSAIDs), and
- quinolone anti-infectives without evidence of clinically significant adverse interactions.
Multimedia: Slideshows, Images & Quizzes
Hair Loss: Alopecia, Thinning Hair in Men and Women
Learn about hair loss (alopecia) in women and men. Discover hair loss causes and treatments like shampoos and drugs, as well as...
19 Health Problems in Men: Snoring, Hair Loss, and More
What are the biggest body health issues that plague men? Most men struggle with belly fat, back hair, sweating, erectile...
Women’s Hair Loss: Causes, Treatments, and Solutions
Hair loss in women has many causes. Menopause is one cause of hair loss in women over 50. Hormones, medications, and stress are...
Hair Loss Quiz: Test Your Medical IQ
True or false: Genetic hair loss comes from the mother's side of the family. Take the Hair Loss Quiz to learn about your hair....
Picture of Alopecia Areata
A common hair loss condition, alopecia areata, usually starts as a single quarter-sized circle of perfectly smooth baldness. See...
Picture of Traction Alopecia
Tight braids and ponytails can pull hard enough on hairs to make them fall out. See a picture of Traction Alopecia and learn more...
Hair Loss: Conditions That Can Cause Body Hair Loss
Some kinds of body hair loss -- or extra growth -- can be a sign of another health condition. Find out what yours might mean.
Picture of Alopecia Areata (Nails)
Pitting in organized transverse rows giving the nail a "hammered brass" appearance. See a picture of Alopecia Areata (Nails) and...
Picture of Alopecia Areata
Alopecia areata is a type of hair loss that occurs when your immune system mistakenly attacks hair follicles, which is where hair...
Picture of Female Pattern Baldness
Mistakenly thought to be a strictly male disease, women make up a significant percentage of American hair loss sufferers. See a...
Picture of Male Pattern Baldness
The male pattern baldness (MPB) form of androgenetic alopecia (there is also a female pattern baldness) accounts for more than...
Men's Hair Loss: Treatments and Solutions
Receding hairlines, thinning, bald spots -- learn to prevent further hair loss and make the most of what you've got. WebMD shows...
Related Disease Conditions
Hair Loss (Alopecia)
There are many causes of scalp hair loss. This featured article covers the common ones such as patchy hair loss (alopecia areata, trichotillomania, and tinea capitis), telogen effluvium, and androgenetic alopecia (male-pattern baldness, female-pattern baldness).
Alopecia areata is a condition that causes hair loss on the scalp and sometimes other parts of the body. It is believed to be caused by an abnormality of the immune system that causes the body's immune system to attack the hair follicles. Typically, hair regrows within a year without treatment. Steroid injections, creams, and shampoos may be used during treatment.
Effective Ways to Stop Hair Loss in Men
Hair loss is one of the common problems in men. There could be many causes of hair loss that include diet, mineral deficiency, medications, stress, pollution, and genetics.
Cosmetic Procedures for Hair Loss
Second Source article from WebMD
What Are the Best Ways to Get Thicker Hair?
Hair loss and damage can occur due to genetic tendency for baldness, hormones (pregnancy), medications (cancer medication) and other medical illnesses (stress, thyroid disease or autoimmune diseases). Home remedies for thicker hair include massaging the scalp with oil, using minoxidil, applying hair masks or aloe vera, eating a balanced diet or taking hair growth supplements and nutrients.
How Can I Grow My Hair Faster Naturally?
Hair, on average, grows about half an inch every month. There is no proven scientific way to make hair grow faster. Certain home remedies may help increase hair thickness and thus hair length, which include massaging your scalp, trimming your hair, brushing gently, using conditioner, eating a nutrient dense diet and other strategies.
Treatment & Diagnosis
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.